Bal Pharma Limited (NSE:BALPHARMA)
India · Delayed Price · Currency is INR 65.88
-1.01 (-1.51%)
Mar 27, 2026, 3:29 PM IST
Bal Pharma Market Cap
Bal Pharma has a market cap or net worth of 1.05 billion as of March 27, 2026. Its market cap has decreased by -24.91% in one year.
Market Cap
1.05B
Enterprise Value
2.51B
Revenue
3.09B
Ranking
n/a
PE Ratio
12.91
Stock Price
65.88
Market Cap Chart
Since December 20, 2004, Bal Pharma's market cap has increased from 559.95M to 1.05B, an increase of 87.26%. That is a compound annual growth rate of 2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.05B | -10.09% |
| Dec 31, 2025 | 1.17B | -39.96% |
| Dec 31, 2024 | 1.94B | 23.18% |
| Dec 29, 2023 | 1.58B | 10.20% |
| Dec 30, 2022 | 1.43B | -8.67% |
| Dec 31, 2021 | 1.57B | 96.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 11.87B |
| Sigachi Industries | 7.16B |
| Valiant Laboratories | 3.09B |
| Bafna Pharmaceuticals | 2.78B |
| Nectar Lifesciences | 2.00B |
| Brooks Laboratories | 1.38B |
| Alpa Laboratories | 1.19B |
| Par Drugs and Chemicals | 1.07B |